| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.1M | +136.1% |
| Cost of Revenue | $3.6M | +205.8% |
| Gross Profit | $4.6M | +100.3% |
| R&D Expense | $779K | +4.8% |
| SG&A Expense | $11.3M | +74.0% |
| Operating Income | -$7.5M | -51.6% |
| Net Income | -$6.0M | +48.8% |
| EPS (Basic) | -$1.63 | +99.1% |
| EPS (Diluted) | -$1.63 | +99.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -83.0% |
| Accounts Receivable | $102K | -11.3% |
| Inventory | $374K | -59.0% |
| Current Assets | $2.2M | -75.6% |
| Total Assets | $3.3M | -66.2% |
| Current Liabilities | $2.3M | -84.4% |
| Total Liabilities | $2.4M | -84.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | -4.8% |
| Capital Expenditures | $469K | -6.6% |
| Investing Cash Flow | -$469K | +6.6% |
| Financing Cash Flow | -$717K | -109.3% |
| Free Cash Flow | -$5.6M | -3.8% |
| $926K |
| +117.9% |